He Designed Drugs to Save His Children. Now He's Working to Save Biotech, Too.
John Crowley will become a top lobbyist for the industry as it confronts investor skepticism and regulatory challenges.
John Crowley will become a top lobbyist for the industry as it confronts investor skepticism and regulatory challenges.